Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00182988 · ClinicalTrials.gov registry record
Alzheimer's Caregiver Communication Study
A clinical trial, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- 140
- Enrollment target
NCT00182988: Completed study, sponsored by National Institute on Aging (NIA).
NCT00182988 is a clinical trial that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 140 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00182988 has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- 140 participants
- Enrollment target
Study Summary
The point of this research is to improve the communicative relationship between the caregiver and care receiver. It is input from the caregiver on these communicative behaviors that will inform the process of understanding how to reduce the caregiver burden that comes from this communicative relationship.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2004-10 |
| Est. Completion | 2007-12 |
What the finished NCT00182988 record still lists
NCT00182988 is an observational study that tracks outcomes without assigning an intervention. The registered 140 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00182988 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00182988 about?
NCT00182988 is a clinical study titled "Alzheimer's Caregiver Communication Study". The point of this research is to improve the communicative relationship between the caregiver and care receiver. It is input from the caregiver on these communicative behaviors that will inform the process of understanding how to reduce the caregiver burden that comes from this communicative relatio...
What is the current status of trial NCT00182988?
This trial is currently completed. The enrollment target is 140 participants. The study started on 2004-10. Estimated completion is 2007-12.
Who is sponsoring clinical trial NCT00182988?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01419561 · 140 participants · Phase 2
Natural History Study of the KSHV Inflammatory Cytokine Syndrome (KICS)
- NCT01624805 · 140 participants · Phase 2
Methylprednisolone, Horse Anti-Thymocyte Globulin, Cyclosporine, Filgrastim, and/or Pegfilgrastim or Pegfilgrastim Biosimilar in Treating Patients With Aplastic Anemia or Low or Intermediate-Risk Myelodysplastic Syndrome
- NCT02369770 · 140 participants · NA
Sensory-Motor Rehabilitation Post Stroke
- NCT02455193 · 140 participants · NA
Neuronal Effects of Exercise in Schizophrenia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia